Financials in USD. Standardized financial statements.
A compact view of how UV Flu Technologies, Inc. turns revenue into operating income and net income.
| Metric | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $175,513 | $113,743 | $213,797 | $155,871 | $155,749 | $107,703 | $18,000 | $17,900 | $0 |
| Revenue Growth? | +54.3% | -46.8% | +37.2% | +0.1% | +44.6% | +498.4% | +0.6% | 0.0% | 0.0% |
| Cost of Revenue? | $155,611 | $107,517 | $116,862 | $71,243 | $79,969 | $85,582 | $11,120 | $9,500 | $0 |
| Gross Profit? | $19,902 | $6,226 | $96,935 | $84,628 | $75,780 | $22,121 | $6,880 | $8,400 | $0 |
| Gross Margin? | +11.3% | +5.5% | +45.3% | +54.3% | +48.7% | +20.5% | +38.2% | +46.9% | 0.0% |
| Operating Expenses? | $949,855 | $1.02M | $1.01M | $849,191 | $614,971 | $566,728 | $27,730 | $76,038 | $39,702 |
| Operating Income? | -$929,953 | -$1.02M | -$911,573 | -$764,563 | -$784,569 | -$544,607 | -$20,850 | -$67,638 | -$39,702 |
| EBITDA? | -$875,523 | -$924,856 | -$910,109 | -$736,078 | -$538,521 | -$545,720 | -$16,928 | -$65,496 | -$42,555 |
| Income Before Tax | -$946,666 | -$993,371 | -$946,660 | -$737,538 | -$1.03M | -$543,494 | -$20,828 | -$68,355 | -$36,849 |
| Income Tax Expense | $0 | $0 | $0 | $57,118 | $309,882 | $22,659 | -$22 | $0 | $0 |
| Net Income? | -$946,666 | -$993,371 | -$946,660 | -$821,681 | -$849,073 | -$566,153 | -$20,828 | -$68,355 | -$36,849 |
| EPS? | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.06 | $-0.05 | $-0.00 | $-0.00 | $-0.00 |
| Diluted EPS? | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.06 | $-0.05 | $-0.00 | $-0.00 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality